Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 253
Filter
1.
Rev. cuba. pediatr ; 93(3): e1112, 2021. tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1347536

ABSTRACT

Objetivo: Determinar la diferencia de incidencia de enterocolitis necrotizante asociada a transfusión en recién nacidos pretérmino con y sin implementación de un protocolo de ayuno peritransfusional. Métodos: Estudio observacional retrospectivo. Se incluyeron todos los recién nacidos pretérmino que fueron transfundidos con unidad de glóbulos rojos entre julio 2015 y octubre 2016 en la unidad de recién nacidos un centro de tercer nivel de Colombia. El protocolo de ayuno peritransfusional se inició a partir de abril 2016. La enterocolitis necrotizante asociada a transfusión se definió como enterocolitis necrotizante presentada dentro de las 48 horas posteriores a la transfusión. Se analizaron variables demográficas, alimentación, número de transfusiones y variables asociadas a enterocolitis necrotizante. Resultados: Durante el tiempo de estudio, 148 recién nacidos prematuros necesitaron al menos una transfusión de glóbulos rojos que representaron 385 eventos de transfusión. Se informaron siete casos de enterocolitis necrotizante asociada a transfusión. La incidencia acumulada global fue 4,7 por ciento (3,6 por ciento con protocolo de ayuno peritransfusional y 6,3 por ciento sin protocolo), la tasa de incidencia global de enterocolitis necrotizante asociada a transfusión fue 18/1000 personas-transfusión (IC95 por ciento 7-37/1000 personas-transfusión), mayor en el grupo sin protocolo (28/1000 personas-transfusión) que en el grupo con protocolo (12/1000 personas-transfusión), pero sin significación estadística. Conclusiones: La implementación del protocolo de ayuno peritransfusional podría disminuir la incidencia y gravedad de la enterocolitis necrotizante asociada a transfusión. Se requieren estudios prospectivos para establecer la relación entre la alimentación enteral durante la transfusión y la enterocolitis necrotizante(AU)


Objective: Determine the difference in incidence of transfusion-associated necrotizing enterocolitis in preterm newborns with and without implementation of a peri-transfusion fasting protocol. Methods: Retrospective observational study. All preterm newborns that were transfused with red blood cell units during the period from July 2015 to October 2016 in the newborns´ unit at a third level of care center in Colombia were included. The peri-transfusion fasting protocol started on April 2016. Transfusion-associated necrotizing enterocolitis was defined as necrotizing enterocolitis presented within 48 hours after the transfusion. Demographic variables, feeding, number of transfusions and variables associated with necrotizing enterocolitis were analyzed. Results: During the study time, 148 premature newborns needed at least one transfusion of red blood cells that accounted for 385 transfusion events. Seven cases of transfusion-associated necrotizing enterocolitis were reported. The overall cumulative incidence was 4.7 percent (3.6 percent with peri-transfusion fasting protocol and 6.3 percent without protocol), the overall incidence rate of transfusion-associated necrotizing enterocolitis was 18/1000 people-transfusion (IC 95 percent 7-37/1000 people-transfusion); it was higher in the group without protocol (28/1000 people-transfusion) than in the group with protocol (12/1000 people-transfusion), but without statistical significance. Conclusions: Implementation of the peri-transfusion fasting protocol may decrease the incidence and severity of necrotizing enterocolitis associated with transfusion. Prospective studies are required to establish the relationship between enteral feeding during transfusion and necrotizing enterocolitis(AU)


Subject(s)
Humans , Infant, Newborn , Infant, Premature , Fasting , Erythrocyte Transfusion/methods , Enterocolitis, Necrotizing/epidemiology , Prospective Studies , Observational Studies as Topic
2.
Hematol., Transfus. Cell Ther. (Impr.) ; 43(1): 58-64, Jan.-Mar. 2021. tab
Article in English | LILACS | ID: biblio-1154302

ABSTRACT

ABSTRACT Background: The allogeneic transfusion-related immunomodulation (TRIM) may be responsible for an increase in survival of renal transplants but in contrast it could increase the rate of bacterial infections or the recurrence rate of tumors post-operatively. Objective: This review focuses in the implications of perioperative allogeneic transfusions on the immune-inflammatory response of surgical transfused patients. Results: ABTs modify immune functions in recipients including decrease of the number of lymphocytes; decrease the CD4 cells; decrease the CD4/CD8 T-cell ratio; decrease NK cells; and decrease the lymphocyte response to mitogens. TRIM effects may be mediated by allogeneic white cells present in blood products; soluble peptides present in transfused plasma; and/or biologic mediators released into the supernatant of blood units. A recent systematic review and meta-analysis including 36 clinical observational studies (n = 174,036) concluded that perioperative ABTs not only decreased overall survival and reduced colorectal cancer-specific survival. Furthermore ABTs increased the rate of infectious, cardiac, pulmonary and anastomotic complications in colorectal cancer patients undergoing surgery. Conclusions: It has been demonstrated by laboratory tests that TRIM is associated with transfusion recipient immune alterations but its influence in colorectal cancer recurrence after resection remains controversial though may exist. Surgical techniques reducing intraoperative blood loss have limited the number of ABTs perioperatively, however increase in mortality continues to be reported in literature after ABT in colorectal cancer surgery. Poor survival associated to TRIM in colorectal cancer might be due to higher number of allogeneic transfused units and/or prolonged length of blood storage.


Subject(s)
Humans , Transplantation, Homologous , Colorectal Neoplasms , Erythrocyte Transfusion , Immunomodulation , Immunity , Prognosis , Blood Transfusion
3.
Rev. bras. ter. intensiva ; 33(1): 154-166, jan.-mar. 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1289057

ABSTRACT

RESUMO Considera-se que a transfusão de eritrócitos melhora a respiração celular durante o choque séptico. Contudo, seu impacto agudo no transporte e no metabolismo de oxigênio nessa condição ainda é amplamente debatido. O objetivo deste estudo foi avaliar o impacto da transfusão de eritrócitos na microcirculação e no metabolismo do oxigênio em pacientes com sepse e choque séptico. Conduzimos um levantamento nas bases de dados MEDLINE®, Elsevier e Scopus. Incluímos estudos realizados com seres humanos adultos com sepse e choque séptico. Realizamos uma revisão sistemática e metanálise com utilização do modelo de efeitos aleatórios de DerSimonian e Laird. Consideramos significante valor de p < 0,05. Incluíram-se na análise 19 manuscritos, correspondentes a 428 pacientes. As transfusões de eritrócitos se associaram com aumento de 3,7% na média combinada de saturação venosa mista de oxigênio (p < 0,001), diminuição de razão de extração de oxigênio de -6,98 (p < 0,001) e nenhum efeito significante no índice cardíaco (0,02 L/minuto; p = 0,96). Obtiveram-se resultados similares em estudos que incluíram mensurações simultâneas de saturação venosa mista de oxigênio, razão de extração de oxigênio e índice cardíaco. As transfusões de eritrócitos levaram a aumento significante na proporção de pequenos vasos perfundidos (2,85%; p = 0,553), enquanto os parâmetros de oxigenação tissular revelaram aumento significante no índice de hemoglobina tissular (1,66; p = 0,018). Estudos individuais relataram melhoras significantes na oxigenação tissular e nos parâmetros microcirculatórios sublinguais em pacientes com microcirculação alterada na avaliação inicial. A transfusão de eritrócitos pareceu melhorar o metabolismo sistêmico de oxigênio com aparente independência de variações no débito cardíaco. Observaram-se alguns efeitos benéficos para a oxigenação tissular e parâmetros microcirculatórios, em particular em pacientes com alterações iniciais mais graves. São necessários mais estudos para avaliar seu impacto clínico e individualizar as decisões relativas à transfusão.


ABSTRACT Red blood cell transfusion is thought to improve cell respiration during septic shock. Nevertheless, its acute impact on oxygen transport and metabolism in this condition remains highly debatable. The objective of this study was to evaluate the impact of red blood cell transfusion on microcirculation and oxygen metabolism in patients with sepsis and septic shock. We conducted a search in the MEDLINE®, Elsevier and Scopus databases. We included studies conducted in adult humans with sepsis and septic shock. A systematic review and meta-analysis were performed using the DerSimonian and Laird random-effects model. A p value < 0.05 was considered significant. Nineteen manuscripts with 428 patients were included in the analysis. Red blood cell transfusions were associated with an increase in the pooled mean venous oxygen saturation of 3.7% (p < 0.001), a decrease in oxygen extraction ratio of -6.98 (p < 0.001) and had no significant effect on the cardiac index (0.02L/minute; p = 0,96). Similar results were obtained in studies including simultaneous measurements of venous oxygen saturation, oxygen extraction ratio, and cardiac index. Red blood cell transfusions led to a significant increase in the proportion of perfused small vessels (2.85%; p = 0.553), while tissue oxygenation parameters revealed a significant increase in the tissue hemoglobin index (1.66; p = 0.018). Individual studies reported significant improvements in tissue oxygenation and sublingual microcirculatory parameters in patients with deranged microcirculation at baseline. Red blood cell transfusions seemed to improve systemic oxygen metabolism with apparent independence from cardiac index variations. Some beneficial effects have been observed for tissue oxygenation and microcirculation parameters, particularly in patients with more severe alterations at baseline. More studies are necessary to evaluate their clinical impact and to individualize transfusion decisions.


Subject(s)
Humans , Shock, Septic/therapy , Sepsis/therapy , Oxygen , Erythrocyte Transfusion , Microcirculation
4.
Medwave ; 20(10): e8060, 18 nov. 2020.
Article in English, Spanish | LILACS | ID: biblio-1145816

ABSTRACT

Introducción La medicina transfusional desarrolla y difunde pautas que rigen las condiciones óptimas para transfundir. El objetivo de este artículo es revisar la evidencia que existe actualmente en relación con el uso de hemocomponentes. Los temas abordados son fisiopatología, transfusión de glóbulos rojos, corrección profiláctica de las coagulopatías, reversión del efecto de coumadínicos y desencadenantes fisiológicos de la transfusión. Métodos Se utilizaron los portales web y bases de datos de PubMed, Scholar Google, ScienceDirect, SciELO y Cochrane, además de documentos oficiales publicados en la Sociedad Chilena de Hematología. Se incluyeron artículos de los últimos 10 años, de los cuales, 42 respondieron a los objetivos planteados para esta revisión narrativa de literatura. Conclusión En primer lugar, existe controversia entre dos tipos de estrategias al momento de abordar la práctica transfusional de glóbulos rojos: una estrategia liberal y una estrategia restrictiva. En segundo lugar, para el manejo de las coagulopatías, los tiempos de la coagulación no reflejan la verdadera capacidad de coagular de los pacientes. En tercer lugar, para revertir el efecto de coumadínicos, bastaría con la administración de vitamina K por sobre el uso de plasma fresco congelado. En cuarto lugar, el uso de desencadenantes fisiológicos evaluaría el momento óptimo para poder transfundir.


Introduction Transfusion medicine develops and disseminates guidelines that govern the optimal conditions for transfusion. The purpose of this article is to review the current evidence on the use of blood components. Methods We searched PubMed, Scholar Google, ScienceDirect, SciELO and Cochrane web portals, as well as official documents published in the Chilean Society of Hematology. Articles from the last ten years were included, of which 42 were appropriate for this narrative literature review. Conclusion First of all, there is a controversy between two types of strategies regarding the practice of red blood cell transfusion: a liberal strategy and a restrictive strategy. Second, for the management of coagulopathies, clotting times do not reflect the true ability of patients to clot. Third, to reverse the effect of coumadin, the administration of vitamin K would suffice over the use of fresh frozen plasma. Fourth, the use of physiological triggers could help define the best time for a transfusion.


Subject(s)
Humans , Erythrocyte Transfusion , Chile
5.
Rev. cuba. anestesiol. reanim ; 19(2): e588, mayo.-ago. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1126353

ABSTRACT

Introducción: Para mejorar la estabilidad hemodinámica, trastornos de la coagulación, perfusión hística, capacidad de transporte de oxígeno, entre otros, en el paciente crítico se hace necesario la transfusión de sangre y derivados. Objetivo: Caracterizar la población de pacientes graves que recibieron tratamiento con sangre y hemoderivados. Métodos: Se realizó un estudio descriptivo y transversal en 199 pacientes ingresados en la unidad de cuidados intensivos del Hospital General Orlando Pantoja Tamayo del municipio Contramaestre, provincia Santiago de Cuba, desde enero de 2016 hasta abril de 2019. Las variables analizadas fueron: edad, sexo, causas de hemoterapia, tipo de componente sanguíneo empleado, frecuencia de administración, reacciones adversas y estado al egreso. Se utilizó el porcentaje para resumir la información, así como el test chi cuadrado para identificar asociación estadística. Resultados: Predominaron el sexo femenino (56,7 por ciento) y la edad comprendida entre 65 años y más, con el diagnóstico de politraumatizados, sangrado digestivo alto y sepsis. El concentrado de hematíes fue el más empleado y la frecuencia de administración, en una ocasión, fue en la categoría que más reacciones adversas se encontró (56,6 por ciento); el empleo en cuatro o más ocasiones incrementó la mortalidad. Conclusiones: El concentrado de hematíes fue el hemoderivado más administrado, la administración en una ocasión fue la que más reacciones adversas provocó y la mayoría fueron del tipo inmediatas inmunológicas(AU)


Introduction: To improve hemodynamic stability, coagulation disorders, tissue perfusion, oxygen transport capacity, among others, the transfusion of blood and plasma derivatives is necessary in the critically-ill patient. Objective: To characterize the population of seriously-ill patients who received treatment with blood and hemoderivatives. Methods: A descriptive and cross-sectional study was carried out with 199 patients admitted to the intensive care unit of Orlando Pantoja Tamayo General Hospital in Contramaestre Municipality, Santiago de Cuba Province, from January 2016 to April 2019. The variables analyzed were age, sex, causes for hemotherapy, type of blood component used, frequency of administration, adverse reactions, and discharge status. Percentage was used to summarize the information. Also, the chi-square test was used to identify statistical association. Results: There was a predominance of the female sex (56.7%) and of the age 65 years and older, with diagnosis of polytrauma, high digestive bleeding, and sepsis. The red blood cell concentrate was the most used and the frequency of administration, on one occasion, occurred in the category with the highest amount of adverse reactions (56.6%). Administration on four or more occasions increased mortality. Conclusions: The red blood cell concentrate was the most administered hemoderivative. Administration on one occasion that caused the most adverse reactions and most were immediate immunological ones(AU)


Subject(s)
Humans , Middle Aged , Aged , Intensive Care Units , Epidemiology, Descriptive , Cross-Sectional Studies , Erythrocyte Transfusion/methods , Blood-Derivative Drugs
6.
Arch. argent. pediatr ; 118(2): 109-116, abr. 2020. ilus, tab
Article in English, Spanish | LILACS, BINACIS | ID: biblio-1099860

ABSTRACT

Introducción. La anemia es una complicación para los recién nacidos de muy bajo peso al nacer, y los exámenes de laboratorio son un factor de riesgo preponderante. Más del 50 % recibe, al menos, una transfusión de glóbulos rojos. Estas se han asociado a mayor riesgo de infecciones, hemorragia intracraneal, enterocolitis necrotizante y displasia broncopulmonar. En 2012, se implementó, en el Hospital Italiano de Buenos Aires, una estrategia de menor volumen de extracción de sangre por flebotomía. El objetivo del presente estudio fue evaluar su asociación con el número detransfusiones.Métodos. Estudio cuasiexperimental del tipo antes/después. Se comparó el número de transfusiones entre dos grupos de prematuros de muy bajo peso con diferente volumen de extracción. Se evaluó la correlación entre el volumen extraído y el número de transfusiones estimando el coeficiente de Spearman. Para ajustar por confundidores, se realizó un modelo de regresión logística.Resultados. Se incluyeron en el estudio 178 pacientes con edad gestacional media de 29,4 semanas (desvío estándar: 2,7) y peso al nacer de 1145 gramos (875-1345). El perfil de la serie roja inicial fue similar entre ambos grupos. El número de transfusiones (p = 0,017) y el volumen transfundido (p = 0,048) disminuyeron significativamente. El coeficiente de correlación resultó de 0,83. En el análisis multivariado, volumen de extracción y peso al nacer se asociaron a un requerimiento mayor de 3 transfusiones.Conclusión. Un menor volumen de extracción de sangre en prematuros de muy bajo peso está asociado de manera independiente a menor requerimiento transfusional.


Introduction. Anemia is a complication in very low birth weight (VLBW) infants, and lab tests are a predominant risk factor. At least one red blood cell transfusion is given in more than 50 % of cases. Transfusions are associated with a higher risk for infections, intracranial hemorrhage, necrotizing enterocolitis, and bronchopulmonary dysplasia. In 2012, Hospital Italiano de Buenos Aires implemented a strategy to collect a lower blood volume by phlebotomy. The objective of this study was to assess its association with the number of transfusions.Methods. Before-and-after, quasi-experimental study. The number of transfusions was compared between two groups of VLBW preterm infants with different blood collection volumes. The correlation between the collection volume and the number of transfusions was assessed estimating Spearman's coefficient. A logistic regression model was used to adjust for confounders.Results. The study included 178 patients with a mean gestational age of 29.4 weeks (standard deviation: 2.7) and a birth weight of 1145 g (875-1345). The baseline red series profile was similar between both groups. The number of transfusions (p = 0.017) and the transfusion volume (p = 0.048) decreased significantly. The correlation coefficient was 0.83. In the multivariate analysis, collection volume and birth weight were associated with a requirement of more than three transfusions.Conclusion. A lower blood collection volume in VLBW preterm infants is independently associated with fewer transfusion requirements.


Subject(s)
Humans , Male , Female , Infant, Newborn , Blood Volume , Erythrocyte Transfusion , Phlebotomy/adverse effects , Infant, Premature , Infant, Very Low Birth Weight , Erythrocyte Indices , Non-Randomized Controlled Trials as Topic , Anemia, Neonatal/prevention & control , Anemia, Neonatal/therapy
7.
Hematol., Transfus. Cell Ther. (Impr.) ; 42(1): 12-17, Jan.-Mar. 2020. tab, graf
Article in English | LILACS | ID: biblio-1090481

ABSTRACT

Abstract Introduction About 10% of sickle cell anemia patients will have ischemic stroke. Adams showed stroke incidence reduction in children receiving monthly erythrocyte transfusions by reducing transcranial Doppler (TCD) velocities. Since then, chronic transfusion is recommended as primary stroke prophylaxis. This study aims to assess the effectiveness of chronic transfusions as stroke prophylaxis. Method Retrospective study, reviewing medical records from 15 sickle cell anemia patients undergoing chronic transfusion. Data collected were age, sex, adverse reactions, stroke, hemoglobin, reticulocytes, ferritin, HbS and TCD values (baseline, after 12 and 24 months of treatment). Results The mean age was 118.67 ± 41.40 months; six patients experienced allergic reactions. No stroke was recorded. One patient had alloimmunization. There was a decrease in the HbS rate and an increase in hemoglobin values in the first 12 months. Values were maintained after 24 months, but with no improvement of data. Before treatment, the mean HbS rate was 75.18%±11.69; after 12 months, 41.63 ± 14.99 and after 24 months, 43.78 ± 10.6. Thirteen patients initiated chelation after 12 months from the beginning of chronic transfusions and ferritin decline after 24 months. Pre-transfusional TCD velocities were 204.28 ± 9.41 cm/s (right) and 198.85 ± 33.37 cm/s (left). After a 12-month treatment, these values were 158.5 ± 28.89 cm/s and 157.62 ± 34.43 cm/s, respectively, and this reduction was statistically significant (p = 0.002 right and p = 0.02 left). After 24 months, these values were 149.63 ± 26.95 cm/s (right) and 143.7 ± 32.27 cm/s (left). Conclusion Significant reduction of TCD velocity occurred after treatment with chronic transfusion in sickle cell anemia patients, leading to a normal or conditional test and reducing stroke risk in all but one patient.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Child , Ultrasonography, Doppler, Transcranial , Erythrocyte Transfusion , Stroke , Anemia, Sickle Cell
8.
Curitiba; s.n; 20200304. 112 p. ilus, tab, graf.
Thesis in Portuguese | LILACS, BDENF | ID: biblio-1127726

ABSTRACT

Introdução: O Cateter Central de Inserção Periférica (PICC) é uma tecnologia dura amplamente utilizada em Unidade de Terapia Intensiva Neonatal. Quando o neonato necessita de transfusão de concentrado de hemácias, esse cateter é uma alternativa útil para essa terapêutica. Contudo, torna-se necessário conhecer as causas de uma possível ocorrência de obstrução. Objetivos: avaliar a ocorrência de obstrução do cateter central de inserção periférica após a transfusão de concentrado de hemácias realizada em neonatos e estimar a incidência e o tempo livre de obstrução do cateter nas 24 horas após a transfusão. Método: pesquisa com delineamento do tipo coorte prospectiva, com abordagem quantitativa, desenvolvida na Unidade de Terapia Intensiva Neonatal de um hospital de ensino de Curitiba, Paraná. A amostra foi por conveniência e abrangeu os recém-nascidos que necessitaram de transfusão de concentrado de hemácias durante a utilização do PICC no período de janeiro a julho de 2019. A coleta de dados ocorreu mediante observação direta da transfusão, e da busca e registro de informações contidas nos prontuários dos recém-nascidos até 24 horas após a transfusão. O instrumento de coleta de dados abrangeu variáveis relacionadas aos recém-nascidos, aos PICC e ao desfecho. Resultados: Foram realizadas 46 transfusões de concentrado de hemácias em 24 recém-nascidos por meio de 31 PICC. Predominaram recém-nascidos do sexo masculino (70,8%), prematuros abaixo de 32 semanas (66,7%) e com peso inferior a 1500g (62,5%). Todos os cateteres eram mono lúmens, inseridos em sua maioria (35,4%) nos membros inferiores e 80,6% encontravam-se em posição central no momento da transfusão. Todos os cateteres estavam pérvios no momento da transfusão. Em pouco mais da metade (52,2%) dos PICC estava sendo infundidas três soluções e em 74,2% deles houve apenas uma transfusão de Concentrado de Hemácias. Em 100% dos cateteres foi realizado flushing intermitente. Nesta pesquisa, dentre os 31 acompanhados, um PICC obstruiu 15 minutos após o término da transfusão. A incidência de obstrução foi de 2,2% dos eventos de transfusão, e a probabilidade do PICC livre de obstrução foi de 97,8% 24 horas após a transfusão de concentrado de hemácias. Conclusões: os resultados permitem concluir que a hemotransfusão não foi a variável que contribuiu para a obstrução do PICC, e que este pode ser utilizado com segurança no que diz respeito à obstrução do cateter.


Introduction: The Peripherally Inserted Central Catheter (PICC) is a hard technology widely used in Neonatal Intensive Care Units. When the neonate needs red blood cell transfusion, this catheter is a useful alternative for this therapy. However, it is necessary to know the causes of a possible occurrence of obstruction. Objectives: To evaluate the occurrence of Peripherally Inserted Central Catheter obstruction after transfusion of red blood cells done in newborn babies, and to estimate the incidence and the time free of obstruction of the catheter in the 24 hours after the transfusion. Method: This is a research with prospective cohort outline, with a quantitative approach, developed in a Neonatal Intensive Care Unit of a teaching hospital in Curitiba, Parana. The sample was taken by convenience, and it encompassed newborns babies that needed red blood cells transfusion during the use of the PICC in the period of January-July 2019. Data collection was done through direct observation of the transfusion, and through search and registry of information collected from the patient records of new-borns until 24 hours after transfusion. The data collection instrument encompassed the variables related to the new-borns, that of the PICC, and that of the outcomes. Results: 46 red blood cells transfusion were performed on 24 newborns through 31 PICC. Male sex new-borns (70.8%), premature babies under 32 weeks (66.7%), and with weight under 1500g (62.5%) were predominant. All catheters were mono-lumen, most were inserted in the lower limbs (35.4%), and 80.6% were in central position at the moment of transfusion. All catheters were pervious at the moment of transfusion. In barely more than half (52.2%) of the PICC there were three solutions being infused, and in 74.2% there was only one transfusion done. An intermittent flushing was done in 100% of the PICC. In this research, among the 31 subjects, a single PICC was obstructed 15 minutes after the end of transfusion. The incidence of obstruction was that of 2.2%, and the probability of a PICC free of obstruction was that of 97.8% 24 hours after red blood cells transfusion. Conclusions: The results allow the conclusion that blood transfusion was not the variable that contributed for the obstruction of the PICC, and that may be used safely regarding the obstruction of the catheter.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant, Newborn , Catheterization, Central Venous , Catheterization, Peripheral , Intensive Care Units, Neonatal , Erythrocyte Transfusion , Neonatal Nursing , Evidence-Based Practice
9.
Rev. bras. anal. clin ; 52(1): 48-52, 20200330. ilus
Article in Portuguese | LILACS | ID: biblio-1104464

ABSTRACT

Objetivo: Os concentrados de hemácias não estão livres de lesões de estoque, sendo a mais comum a lise das hemácias. Criar uma escala colorimétrica para inspeção visual do grau de hemólise de concentrados de hemácias. Métodos: Foram utilizadas 102 bolsas de concentrados de hemácias (n=36), concentrados de hemácias pobres em leucócitos (n=36) ou de concentrados de hemácias desleucotizadas (n=36), com até 28 dias da produção, em condições padrões de armazenamento e da rotina da Fundação Hemopa. Os valores de hemoglobina e hematócrito foram lidos em contador automatizado. O grau de hemólise foi realizado em amostras de 5 mL do segmento das bolsas, com leitura em espectrofotômetro. O teste de hemólise foi realizado com três gotas de amostras do segmento das bolsas, em tubo seco, adição de 4 mL de solução fisiológica, centrifugação e inspeção visual do sobrenadante (estudo duplo-cego). Para a confecção da escala colorimétrica foram utilizados os resultados de grau de hemólise e teste de hemólise (n=36) e registro fotográfico dos vários níveis de grau de hemólise das bolsas. Para a validação da escala colorimétrica foram realizados grau de hemólise e teste de hemólise para as bolsas restantes (n=66), e com os resultados comparados com a escala proposta (estudo duplo-cego). Resultados: Apenas 7,5% (5/66) das bolsas testadas foram negativas para o teste de hemólise clássico (visual), e positivas quando reavaliadas na escala colorimétrica proposta. Conclusão: A escala colorimétrica proposta mostrou-se simples e reproduzível para definição de teste de hemólise e o grau de hemólise para concentrados de hemácias.


Objective: Red blood cell (RBC) concentrates are not free of stock lesions, the most common of which is lysis of RBC. Create a colorimetric scale for visual inspection of the degree of hemolysis of bag red blood cells. Methods: Eighty-two bags of RBC concentrates (n = 36), RBC concentrates poor in leukocytes (n = 36) or RBC concentrates desleucotizadas (n = 36) were used with up to 28 days of production, under standard storage conditions of the Hemopa Foundation routine. Hemoglobin and hematocrit values were read in automated counter. The degree of hemolysis performed in 5ml samples from the bag segment, with spectrophotometer reading. The hemolysis test was performed with three drops of bag segment samples, in a dry tube, addition of 4 mL of physiological solution, centrifugation and visual inspection of the supernatant (double-blind study). To prepare the colorimetric scale used was the degree of hemolysis and hemolysis test results (n = 36) and photographic records of multiple levels of degree of hemolysis of bags. For the validation of the Colorimetric scale, hemolysis degree and hemolysis test were performed for the remaining bags (n = 66), and the results were compared with the proposed scale (double-blind study). Results: Only 7.5% (5/66) of the tested bags were negative for the classical (visual) hemolysis test, and positive when reevaluated on the proposed colorimetric scale. Conclusion: The proposed colorimetric scale was simple and reproducible for the definition of hemolysis test and the degree of hemolysis for RBC concentrates.


Subject(s)
Erythrocyte Transfusion , Hemotherapy Service , Hemolysis
11.
Journal of Experimental Hematology ; (6): 1307-1311, 2020.
Article in Chinese | WPRIM | ID: wpr-827121

ABSTRACT

OBJECTIVE@#To evaluate the efficacy and safety of different types of red blood cell (RBC) transfusion and hormone therapy in patients with autoimmune hemolytic anemia (AIHA).@*METHODS@#The clinical data and serological characteristics of 40 patients with AIHA treated in our hospital from 2014 to 2018 were collected and analyzed retrospectively. The efficacy and safety of different type of RBC transfusion and hormone therapy were evaluated according to the principle of minimally incompatible RBC transfusion after cross-matching.@*RESULTS@#Among 40 patients with AIHA, the female cases were more than the male cases, the cases of secondary AIHA was more than cases of primary AIHA, and the warm autoantibodies were in the majority. 11 cases of AIHA underwent 26 times minimally incompatible red blood cell transfusions. The total effective rate was 46.2%, the partial efficiency was 23.1%, and total inefficiency was 30.8%. Among them, the same type of non-washing red blood cell group showed efficiency of 42.1%, partial effective rate of 21.1%, and inefficiency of 36.8%; the same type of washed red blood cell group showed efficiency of 57.1%, partial effective rate of 28.6%, and inefficiency of 14.3%. the infusion effects was not significanly different between the two groups, and no hemolytic transfusion reaction occurred. In the hormone-treated group, the complete remission rate was 15.2%, the partial remission rate was 63.6%, and the ineffective rate was 21.2%. Among them, the side effects appeared in 2 patients after using hormones.@*CONCLUSION@#When AIHA patients need blood transfusion, use the same type of non-washed red blood cells or homologous washed cells is relatively safe, and the difference in efficacy is not significant. The partial remission of patients received hormone therapy is much higher than that of red blood cell transfusion, but the side effects easily happen.


Subject(s)
Anemia, Hemolytic, Autoimmune , Autoantibodies , Blood Transfusion , Erythrocyte Transfusion , Erythrocytes , Female , Humans , Male , Retrospective Studies
12.
Rev Assoc Med Bras (1992) ; 66(4): 466-471, 2020. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1136237

ABSTRACT

SUMMARY OBJECTIVE To evaluate the adequacy of the prescription of red cell concentrates by emergency physicians. METHODS A cross-sectional study based on the survey of transfusion requests records completed by emergency physicians, from May/2018 to April/2019, in an emergency hospital. Adequacy in the indication, volume, and subtype (filtered, irradiated, and washed) of prescribed erythrocytes were evaluated. To compare the qualitative data, we used the χ2 test. The significance level adopted was 5%. RESULTS One thousand and twenty-two transfusions were evaluated. The indication, volume, and subtypes were correct in 72.7%, 45.9%, and 81.6% respectively. Transfusion in symptomatic patients presented superior adequacy when compared to asymptomatic individuals with significant statistical difference (indication: 79,6% vs 67.2%, p <0.001; Volume: 63.5% vs 31.7%, p <0.001; subtype: 85.3% vs 78.7%, p 0.006). Among clinical situations, there were more errors in sepsis (39.7%) and pneumonia (36.3%). More than half of the prescriptions presented excessive volume, raising the risk of circulatory overload, observing that the mean age was 60.6 years. The specific analysis of the prescribed subtypes showed adequacy of 17.9% in the filtered, 1.7% in the irradiated, and none in the washed. Thirty transfusions should have been filtered, but the prescriber did not request the subtype. CONCLUSION One hypothesis for the observed inaccuracies is inadequate medical training on the subject, both in undergraduate and medical residency, associated with a lack of continuing education on transfusion protocols. The transfusion Committee received the results of this study with a proposal for continuing education measures on transfusion hemotherapy.


RESUMO OBJETIVO Avaliar a adequação da prescrição de concentrados de hemácias por médicos emergencistas. MÉTODOS Estudo transversal por levantamento de fichas de requisição de transfusões preenchidas por médicos emergencistas, no período de maio de 2018 a abril de 2019, em um hospital de emergências. Foram avaliadas as adequações na indicação, volume e subtipo (filtradas, irradiadas e lavadas) de hemácias prescritas. Para comparação dos dados qualitativos, utilizamos o teste de χ2. O nível de significância adotado foi de 5%. RESULTADOS Foram avaliadas 1.022 transfusões. A indicação, o volume e os subtipos estavam corretos em 72,7%, 45,9% e 81,6%, respectivamente. A transfusão prescrita em pacientes sintomáticos apresentou adequação superior quando comparada aos assintomáticos, com diferença estatística significativa (indicação: 79,6% vs 67,2% - p<0,001; volume: 63,5% vs 31,7% - p<0,001; subtipo: 85,3% vs 78,7% - p 0,006). Entre as situações clínicas, ocorreram mais erros na sepse (39,7%) e pneumonia (36,3%). Mais da metade das prescrições apresentavam volume excessivo, elevando o risco de sobrecarga circulatória, observando-se que a média da idade foi 60,6 anos. A análise específica dos subtipos prescritos apresentou adequação de 17,9% nas filtradas, 1,7% nas irradiadas e nenhuma das lavadas. Trinta transfusões deveriam ter sido filtradas, porém o prescritor não solicitou o subtipo. CONCLUSÃO Uma hipótese para as incorreções observadas é a formação médica inadequada sobre o assunto, tanto na graduação como na residência médica, associada à falta de atualização nos protocolos transfusionais. O comitê transfusional recebeu os resultados deste estudo com proposta de medidas de educação permanente sobre hemoterapia transfusional.


Subject(s)
Humans , Erythrocyte Transfusion , Prescriptions/statistics & numerical data , Blood Transfusion , Cross-Sectional Studies , Emergency Medical Services , Erythrocytes , Middle Aged
13.
Clin. biomed. res ; 40(2): 91-95, 2020.
Article in English | LILACS | ID: biblio-1148106

ABSTRACT

Introduction: To analyze the prevalence of alloantibodies in multiply transfused patients. Methods: This study was a retrospective, exploratory and descriptive study with a quantitative approach. The study sample comprised 185 patients transfused at a referral service in the city of Passo Fundo, Rio Grande do Sul, from January 2016 to February 2018. Results: Overall, the antibodies identified were as follows: anti-E in 47 patients (18%), anti-D and anti-K in 28 patients each (11%), anti-C in 21 patients (8.1%), and inconclusive antibody results in 23 patients (8.9%). Females were a majority (55.7%), mean age was 48.8 years and mean quantity of blood transfused was 7.2 bags. Cardiovascular disorders were the most common comorbidities, in 39 patients (21.2%), followed by oncological disorders, in 38 patients (18.4%). Conclusion: Alloimmunization is an important and frequent clinical condition that increases the risk of hemolytic reactions and is associated with significant patient morbidity and mortality. (AU)


Subject(s)
Humans , Male , Female , Transplant Recipients , Antibodies/analysis , Comorbidity , Immunization/adverse effects , Erythrocyte Transfusion/statistics & numerical data
14.
Einstein (Säo Paulo) ; 18: eAO5446, 2020. tab
Article in English | LILACS | ID: biblio-1133739

ABSTRACT

ABSTRACT Objective To assess the level of knowledge of emergency pediatricians on red blood cell transfusions and their reactions. Methods Written survey with emergency pediatricians from a pediatric hospital. Results Less than 20% of pediatricians showed appropriate knowledge on prescribing red blood cells and recognition of transfusion reactions. There was no significant statistical regarding time since graduation and blood transfusion classes in undergraduate studies or during medical residency. Conclusion Pediatricians have insufficient knowledge about red blood cell transfusions and recognition of transfusion reactions.


RESUMO Objetivo Avaliar o conhecimento de pediatras emergencistas sobre transfusão de concentrados de hemácias e reações transfusionais. Métodos Aplicação de formulário para pediatras emergencistas de um hospital pediátrico. Resultados Menos de 20% dos participantes demonstraram conhecimento adequado sobre prescrição de concentrados de hemácias e reconhecimento de reações transfusionais. Não houve diferença estatística significativa quando avaliados o tempo de formação profissional e o fato de ter recebido aula de hemoterapia na graduação ou na residência médica. Conclusão Os pediatras têm conhecimento insuficiente sobre prescrição de concentrados de hemácias e reconhecimento de reações transfusionais.


Subject(s)
Humans , Child , Erythrocyte Transfusion , Prescriptions/statistics & numerical data , Transfusion Reaction , Erythrocytes , Pediatricians
15.
Rev. cuba. hematol. inmunol. hemoter ; 35(1): e944, ene.-mar. 2019. graf
Article in Spanish | LILACS, CUMED | ID: biblio-1003892

ABSTRACT

La infección por parvovirus B19 humano, es la causa de la mayor parte de los casos de crisis aplásica transitoria que aparecen de forma brusca en pacientes con enfermedades hemolíticas crónicas, como es el caso de la drepanocitosis. Por otra parte, se han descrito unos pocos casos de infección aguda, por parvovirus B19 humano como causa de anemia hemolítica autoinmune, por medio de la formación de anticuerpos dirigidos contra los glóbulos rojos. La asociación entre drepanocitosis y anemias hemolíticas autoinmunes es poco frecuente. Se reporta un caso poco usual de una paciente adulta, con antecedentes de hemoglobinopatía S/C que presentó una crisis aplásica y posteriormente apareció una anemia hemolítica autoinmune diagnosticada en el Instituto de Hematología e Inmunología. Se trató con dosis inmunosupresoras de esteroide, con lo que se alcanzó la remisión de la anemia hemolítica autoinmune(AU)


Infection with human B19 parvovirus is the cause of most cases of transient aplastic crisis that appear in patients with chronic hemolytic diseases, as in the case of sickle cell disease. On the other hand, a few cases of acute infection by human parvovirus B19 have been described as a cause of autoimmune hemolytic anemia, through the formation of antibodies directed against red blood cells. The association between sickle cell disease and autoimmune hemolytic anemia is rare. We report an unusual case of an adult patient, with a history of S C hemoglobinopathy who presented an aplastic crisis and subsequently an autoimmune hemolytic anemia diagnosed at the Institute of Hematology and Immunology, treated with high steroids doses, reaching the remission of autoimmune hemolytic anemia and constitutes the first report in Cuba(AU)


Subject(s)
Humans , Female , Middle Aged , Erythrocyte Transfusion/methods , Anemia, Hemolytic, Autoimmune/complications , Anemia, Hemolytic, Autoimmune/drug therapy , Prednisone/therapeutic use , Anemia, Sickle Cell/complications
16.
Rev. bras. cir. cardiovasc ; 34(1): 33-40, Jan.-Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-985237

ABSTRACT

Abstract Objective: To discover potentially modifiable perioperative predictors for renal replacement therapy (RRT) in patients with cardiac surgery-associated acute kidney injury (CSA-AKI). Methods: A cohort of 1773 consecutive cardiac surgery patients with postoperative acute kidney injury (AKI) from January 2013 to December 2015 were included retrospectively. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The primary outcome was CSA-AKI requiring renal replacement therapy (AKI-RRT). The initiation of RRT was based on clinical judgment regarding severe volume overload, metabolic abnormality (e.g., acidosis, hyperkalemia), and oliguria. Patients with AKI-RRT were matched 1:1 with patients without AKI-RRT by a propensity score, to exclude the influence of patients' demographics, comorbidities, and baseline renal function. Multivariable regression was performed to identify the predictors in the matched sample. Results: AKI-RRT occurred in 4.4% of the entire cohort (n=78/1773), with 28.2% of in-hospital mortality (n=22/78). With the propensity score, 78 pairs of patients were matched 1:1 and the variables found to be predictors of AKI-RRT included the contrast exposure within 3 days before surgery (odds ratio [OR]=2.932), central venous pressure (CVP) >10 mmHg on intensive care unit (ICU) admission (OR=1.646 per mmHg increase), and erythrocyte transfusions on the 1st day of surgery (OR=1.742 per unit increase). Conclusion: AKI-RRT is associated with high mortality. The potentially modifiable predictors found in this study require concern and interventions to prevent CSA-AKI patients from worsening prognosis.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Coronary Artery Bypass/adverse effects , Renal Replacement Therapy/statistics & numerical data , Risk Assessment/methods , Heart Valve Prosthesis Implantation/adverse effects , Acute Kidney Injury/etiology , Acute Kidney Injury/therapy , Postoperative Complications/etiology , Time Factors , Logistic Models , Multivariate Analysis , Predictive Value of Tests , Retrospective Studies , Risk Factors , Hospital Mortality , Erythrocyte Transfusion/statistics & numerical data , Statistics, Nonparametric , Propensity Score , Perioperative Period , Intensive Care Units/statistics & numerical data
17.
Article in Korean | WPRIM | ID: wpr-765647

ABSTRACT

BACKGROUND: Transfusion in neonates and infants can be performed using an electromechanical infusion system that has appropriate accuracy in terms of flow rate, volume, and bolus. However, there are no infusion systems approved for transfusion in Korea. In this study, we evaluate the performance of two electromechanical infusion systems for transfusion in pediatric patients. METHODS: We tested two systems, Baxter and Terumo, using 9 units of leukocyte-filtered red blood cells. The blood samples were delivered through the systems at constant speeds of 10, 30, and 100 mL/hr, and the accuracy in terms of the delivered volume was estimated. Before and after infusion, hemoglobin, hematocrit, plasma hemoglobin, potassium, and lactate dehydrogenase levels were measured in each sample. The percentage of hemolysis (%Hemolysis) was calculated to evaluate the safety of the infusion systems. RESULTS: For Terumo, the mean error rate of the infused volume was less than 5%. We expect that Terumo can transfuse blood at a volume close to the set volume. Further, both infusion systems showed acceptable %Hemolysis levels (mean±standard deviation: Terumo, 0.14±0.04; Baxter, 0.17±0.06). CONCLUSIONS: Both infusion systems can be used safely for transfusion in pediatric patients.


Subject(s)
Erythrocyte Transfusion , Erythrocytes , Hematocrit , Hemolysis , Humans , Infant , Infant, Newborn , Korea , L-Lactate Dehydrogenase , Plasma , Potassium
18.
Article in Chinese | WPRIM | ID: wpr-771911

ABSTRACT

OBJECTIVE@#To explore the blood transfusion data of emergency hemorrhage patients, so as to provide the basis for improving the quality of emergency blood transfusion and guiding clinic rational blood transfusion.@*METHODS@#one thousand emergency blood loss patients once transfused RBC suspension were collected by Recipient Epidemiology and Donor Evaluation Study-III internationals Site range from November 2012 to November 2015. The clinical data including age, sex, clinical diagnosis etc were analyzed retrospectively. According to the quantity of blood transfusion the 1 000 patients were divided into 3 groups: low transfusion volume group(834),moderate transfusion volume group(116) and high transfusion volume group(50), difference was compared among the 3 groups,the transfusion predicting index and risk factor were analyzed by unvariate and multivoriate analyses using SPSS 23.0 software.@*RESULTS@#High volume transfusion group was different from moderate and low volume transfusion in sex, pathogenesis, systolic pressure, hemoglobin level, with or without surgical operation, infusion volume of blood products, the retention time of ICU, total hospitalzed stay and mortality(P<0.05), but there were no differences in age, respiration frequency, temperature before transfusion and creatinine level. The multivarate analysis showed that with or without surgical operation(OR=7.515,95% CI: 3.289-17.174, P=0.000), bleeding volume in surgery(OR=2.626, 95% CI: 1.428-4.828, P=0.043), the amount of transfused red blood cells(OR=2.574, 95% CI: 1.306-5.073, P=0.015), plasma transfusion or no(OR=2.118, 95% CI: 1.184-3.789, P=0.011), cryoprecipitate transfusion or no(OR=5.296, 95% CI: 2.164-12.960, P=0.000) were the independent risk factors for death resulted from emergency blood loss.@*CONCLUSION@#The probability of massive transfusion in the trauma patients is higher,and the massive transfusion associates with increased mortality in the emergency blood loss patients. Surgery operation, bleeding volume in operation, amount of transfused red blood cells, plasma transfusion and cryoprecipitate transfusion may predict the mortality of patients with blood transfusion.


Subject(s)
Blood Transfusion , Erythrocyte Transfusion , Hemorrhage , Humans , Platelet Transfusion , Retrospective Studies
19.
Article in Chinese | WPRIM | ID: wpr-775997

ABSTRACT

Perioperative restrictive red blood cell(RBC)transfusion strategy,in which a trigger of hemoglobin(Hb)<7 g/dl is used,is of great benefits to save blood storage and reduce transfusion-related adverse events including infections,immunologic risks,and circulatory overload.Human body can display a series of compensatory mechanisms to acute anemia,including increased cardiac output,favored oxyhemoglobin dissociation,and lung vascular dilation.Therefore,moderate Hb decrease does not necessarily lead to hypoxemia.Patients undergoing hip surgery or suffering from septic shock and/or upper gastrointestinal bleeding can benefit from restrictive RBC transfusion;however,restrictive transfusion may be associated with adverse outcomes in patients with coronary heart disease or undergoing cardiac surgery.Restrictive RBC transfusion strategies have been included in described in many different guidelines.Most of them recommended Hb<7 g/dl to be a trigger for allogeneic RBC transfusion.For patients with an Hb of 7-10 g/dl,the application of restrictive RBC transfusion should be based on the expected blood loss,compensatory ability,and metabolic rate.


Subject(s)
Erythrocyte Transfusion , Hemoglobins , Humans , Perioperative Care , Practice Guidelines as Topic , Surgical Procedures, Operative
20.
Article in English | WPRIM | ID: wpr-762719

ABSTRACT

PURPOSE: Spontaneously ruptured hepatocellular carcinoma (srHCC) is known to be a life-threatening complication with poor prognosis. Although there are various treatment modalities, there is no definite treatment guideline. The purpose of this study was to review the surgical outcome and prognosis of srHCC treated with intraoperative radiofrequency ablation (RFA) and distilled water peritoneal lavage (DWPL). METHODS: From March 2012 to October 2018, 9 patients with srHCC who underwent emergent surgery were reviewed. After hematoma removal, intraoperative RFA and DWPL were applied to all patients. Hepatectomy was performed if necessary. Patients with multiple tumors, distant metastasis, and vascular tumor involvement in radiologic imaging were excluded. RESULTS: Six of 9 patients with diameters less than 7 cm were able to obtain hemostasis using RFA alone (RFA group). However, 3 patients with a tumor size of more than 10 cm underwent liver resection because they could not obtain hemostasis with RFA (hepatectomy only group). The RFA group had shorter operation time (148.3 ± 31.7 minutes vs. 251.7 ± 20.2 minutes, P < 0.05) and less red blood cell transfusion (5.8 ± 2.5 packs vs. 24.0 ± 11.5 packs, P < 0.05) than the hepatectomy only group. There was no peritoneal metastasis at long-term follow-up in the RFA group. Five-year recurrence-free survival rate was 0% in both groups. However, 5-year overall survival rate was better in the RFA group (83.3% vs. 0%, P < 0.05). CONCLUSION: Intraoperative RFA and DWPL are easy to perform and theoretically the best methods for managing relatively small srHCC.


Subject(s)
Carcinoma, Hepatocellular , Catheter Ablation , Erythrocyte Transfusion , Follow-Up Studies , Hematoma , Hemostasis , Hepatectomy , Humans , Liver , Neoplasm Metastasis , Peritoneal Lavage , Prognosis , Rupture , Survival Rate , Water
SELECTION OF CITATIONS
SEARCH DETAIL